RE:Last target was around 7,50$, sylvain_007 wrote: People spoke about 10$ if GUD return on the finance market. Short term, probably 7$ is possible.
There is a sense of pride with going to market at INCREASED valuations. They want to be able to say that ... if at all possible.
Therefore, I would not look at $10 as an entry point for issuing more shares ... will be higher IMO.
Then again ... can't say for certain as time sensitive opportunities could arise. In such a case, look for cash and debt to be used prior to going to market (if at all possible).
Regardless - they know how to build a drug licensing/marketing firm. Slow and steady wins this race.